Funds and ETFs Intuitive Surgical, Inc.
Equities
ISRG
US46120E6023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
310.42 USD | -0.37% | -1.52% | +16.99% |
Dec. 04 | Morgan Stanley Raises Intuitive Surgical Price Target to $330 From $300, Maintains Equal Weight Rating | MT |
Nov. 21 | It’s Nvidia Day | ![]() |
ETFs positioned on Intuitive Surgical, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.19% | 1 M€ | -9.71% | ||
9.85% | 28 M€ | +28.25% | - | |
9.85% | 108 M€ | +33.41% | ||
9.77% | 26 M€ | +30.01% | ||
9.77% | 7 M€ | +24.76% | - | |
9.69% | 1,780 M€ | +30.02% | ||
8.53% | 131 M€ | -1.53% | ||
7.45% | 4,371 M€ | -3.65% | ||
5.03% | 89 M€ | -2.20% | - | |
4.80% | 11 M€ | 0.00% | - | |
4.80% | 820 M€ | -4.99% | - | |
4.80% | 68 M€ | 0.00% | - | |
4.76% | 4 M€ | -7.34% | ||
4.32% | 16 M€ | 0.00% | - | |
4.32% | 27 M€ | -6.00% | - | |
4.32% | 132 M€ | -7.59% | - | |
3.99% | 158 M€ | +29.97% | - | |
3.85% | 27 M€ | +23.04% | - | |
3.81% | 252 M€ | +10.09% | - | |
3.77% | 146 M€ | +19.61% | ||
3.76% | 26 M€ | +10.67% | - | |
3.63% | 6 M€ | +31.01% | - | |
3.41% | 3 M€ | +16.87% | - | |
3.23% | 4 M€ | +21.55% | - | |
3.23% | 2 M€ | +19.76% | - | |
3.23% | 10 M€ | +18.11% | - | |
3.18% | 10 M€ | +31.66% | - | |
3.10% | 3 M€ | -1.60% | - | |
3.09% | 27 M€ | +18.10% | - | |
2.82% | 5 M€ | +37.29% | - | |
2.59% | 19 M€ | +23.23% | - | |
2.59% | 5 M€ | 0.00% | - | |
2.30% | 41 M€ | 0.00% | - | |
2.21% | 309 M€ | -1.87% | ||
2.21% | 77 M€ | +5.41% | - | |
2.21% | 83 M€ | +4.82% | - | |
2.21% | 1,753 M€ | -.--% | - | |
2.21% | 105 M€ | -4.86% | - | |
2.21% | 1,872 M€ | -.--% | ||
2.20% | 33,985 M€ | -2.78% |
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (56.5%): primarily wrist cuffs;
- sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.5%).
The United States accounts for 66.8% of net sales.
Calendar
2024-01-24
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
310.42USD
Average target price
327.83USD
Spread / Average Target
+5.61%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.99% | 109 B $ | |
-11.06% | 189 B $ | |
-18.06% | 161 B $ | |
+18.76% | 80 501 M $ | |
+11.75% | 63 269 M $ | |
-6.32% | 49 971 M $ | |
-7.28% | 41 958 M $ | |
-15.00% | 37 158 M $ | |
+17.37% | 31 193 M $ | |
-21.75% | 23 955 M $ |
- Stock
- Equities
- Stock Intuitive Surgical, Inc. - Nasdaq
- Funds and ETFs Intuitive Surgical, Inc.